Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Husam S Tarawneh"'
Autor:
Michael A. Thompson, Martin K. Oaks, Maharaj Singh, Karen M. Michel, Michael P. Mullane, Husam S. Tarawneh, Angi Kraut, Kayla J. Hamm
Publikováno v:
Journal of Patient-Centered Research and Reviews, Vol 4, Iss 3, Pp 131-135 (2017)
Infections are a major cause of morbidity and mortality in multiple myeloma (MM), a cancer of the immune system. Vaccination clinical efficacy endpoints have not been demonstrated, and there are limited data on surrogate markers of efficacy. This pil
Externí odkaz:
https://doaj.org/article/f5d1f077220c45c1aeac380556364784
Autor:
Karen M Michel, Kayla J Hamm, Maharaj Singh, Michael A. Thompson, Angi Kraut, Martin K. Oaks, Husam S Tarawneh, Michael P Mullane
Publikováno v:
Journal of Patient-Centered Research and Reviews, Vol 4, Iss 3, Pp 131-135 (2017)
Infections are a major cause of morbidity and mortality in multiple myeloma (MM), a cancer of the immune system. Vaccination clinical efficacy endpoints have not been demonstrated, and there are limited data on surrogate markers of efficacy. This pil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::048ed2e413f99e77133227bc6f92b031
https://europepmc.org/articles/PMC6664348/
https://europepmc.org/articles/PMC6664348/
Autor:
Husam S Tarawneh, Martin K. Oaks, Kayla J Hamm, Michael P Mullane, Angela M Kraut, Maharaj Singh, John O. Richards, Andinet W Alemu, Carla Fuentes, Michael A. Thompson, Thomas S S Smith, Karen M Michel
Publikováno v:
Blood. 128:5607-5607
Background Multiple myeloma (MM) is a cancer of the immune system. Infection is a major cause of morbidity and mortality in MM. Vaccinations (vax) are recommended in MM, but clinical efficacy endpoints have not been demonstrated and surrogate markers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e68dba3f1be9c431803774ec8dd10eae
https://doi.org/10.1182/blood.v128.22.5607.5607
https://doi.org/10.1182/blood.v128.22.5607.5607